Pitt Shield

Colloids, nanoparticles, and materials for imaging, delivery, ablation, and theranostics by focused ultrasound (FUS).

Authors: Yildirim A, Blum NT, Goodwin AP

This review focuses on different materials and contrast agents that sensitize imaging and therapy with Focused Ultrasound (FUS). At high intensities, FUS is capable of selectively ablating tissue with focus on the millimeter scale, presenting an alternative to surgical intervention or management of malignant growth. At low intensities, FUS can be also used for other medical applications such as local delivery of drugs and blood brain barrier opening (BBBO). Contrast agents offer an opportunity to increase selective acoustic absorption or facilitate destructive cavitation processes by converting incident acoustic energy into thermal and mechanical energy. First, we review the history of FUS and its effects on living tissue. Next, we present different colloidal or nanoparticulate approaches to sensitizing FUS, for example using microbubbles, phase-shift emulsions, hollow-shelled nanoparticles, or hydrophobic silica surfaces. Exploring the science behind these interactions, we also discuss ways to make stimulus-responsive, or "turn-on" contrast agents for improved selectivity. Finally, we discuss acoustically-active hydrogels and membranes. This review will be of interest to those working in materials who wish to explore new applications in acoustics and those in acoustics who are seeking new agents to improve the efficacy of their approaches.

Introduction

Purpose Drug delivery with BBB opening
Study Objective To review materials and contrast agents that enhance imaging and therapeutic applications of focused ultrasound, covering mechanisms, nanoparticulate approaches (e.g., microbubbles, phase‑shift emulsions, hollow nanoparticles), stimulus‑responsive “turn‑on” agents, and acoustically‑active hydrogels and membranes.
Animal model / Human subject Not applicable — review article; no experimental organism (no species, strain, age, or sex reported)
Disease model malignant growth (cancer / tumors)
MRI or image guidance method Not specified in the provided text.
Targeted brain region(s) Not Specified
Cargo name and characteristics Material-based acoustic sensitizers for focused ultrasound: phase‑shift emulsions / phase‑change perfluorocarbon droplets (submicron–micron emulsions that vaporize under insonation), hollow‑shelled nanoparticles (acoustically responsive nanoparticles providing cavitation nuclei), hydrophobic silica surfaces/nanoparticles (promote gas nucleation and cavitation), stimulus‑responsive or “turn‑on” contrast agents (acoustically activatable materials for improved selectivity), and acoustically‑active hydrogels and membranes (macroscopic biomaterials that enhance local acoustic absorption and mechanical effects).
Route of administration Not specified in the provided text

Outcomes and Safety

Summary of Outcomes Contrast agents enhance focused ultrasound effects by increasing acoustic absorption and cavitation, enabling more selective tissue ablation at high intensity and improved local drug delivery and blood–brain barrier opening at low intensity.
Duration of biological effect Not reported
Safety-related matter The text does not explicitly discuss safety or adverse effects, though it mentions tissue ablation and "destructive cavitation" (thermal and mechanical effects) which imply potential risks.

Brain Region

Ultrasound Parameters

Ultrasound instrument Not specified in the provided text.
FUS Frequency Not specified in the provided text
FUS Intensity Not specified
FUS Pressure None reported
FUS Mode pulsed
Pulse duration Not reported
Duration of a single FUS session Not reported in the provided text
Focal Characteristics millimeter scale
Treatment frequency Not applicable — review article; no treatment sessions reported

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search